Scientific Proof

Results based on laboratory testing
Scientific data repeatedly shows that ActivePure® is the most powerful air and surface purification technology ever discovered.

ActivePure Technology has been proven effective against a broad spectrum of clinically relevant pathogens. Every pathogen has a different level of resistance which is outlined in the hierarchy of pathogens below. This hierarchy is used to help predict the ability of a device or chemical to kill an emerging pathogen. The founding principle, with some exceptions, is that if you are able to demonstrate effectiveness on a higher-class pathogen at the top of the pyramid then there is a presumed level of efficacy against lower-class pathogens at the bottom.

You will see that ActivePure has proven 99.99%+ effectiveness against Bacillus Globigii spores. By achieving this, we are able to claim efficacy against lower-class pathogens at the bottom of the pyramid, like SARS-CoV-2 responsible for COVID-19. We also have test results against SARS-CoV-2. Click here to review our COVID-19 specific test results.

To learn more about the hierarchy of pathogens, visit the Environmental Protective Agency (EPA) website to review Dr. William Rutala’s Overview of Current Disinfection Hierarchy Models or download their white paper here.

MS2 bacteriophage RNA Virus

Reduction of Airborne Contaminants
99.9999%

Reduction after 60 minutes treatment


NEW ACTIVEPURE® MEDICAL UNIT TESTING
Testing done at Aerosol Research and Engineering Laboratories, complying with FDA Protocols in a FDA Certified Compliant Laboratory Net Log Reduction of MS2 Bacteriophage Virus Bioaerosol

Average Percent RNA Virus Reduction
0 minute 30 minutes 60 minutes 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% >99.999% >99.9999% (5-log) (6-log) Before Treatment After Treatment

Phi-X174 bacteriophage DNA Virus

Reduction of Airborne Contaminants
99.993%

Reduction after 60 minutes treatment


NEW ACTIVEPURE® MEDICAL UNIT TESTING
Testing done at Aerosol Research and Engineering Laboratories, complying with FDA Protocols in a FDA Certified Compliant Laboratory Net Log Reduction Phi-X174 of Bacteriophage Virus Bioaerosol

Average Percent DNA Virus Reduction 0 minute 30 minutes 60 minutes 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% >99.99% >99.993% (4-log) (4-log) Before Treatment After Treatment

Staphylococcus epidermidis – Gram-positive Bacteria

Reduction of Airborne Contaminants
99.9999%

Reduction after 60 minutes treatment


NEW ACTIVEPURE® MEDICAL UNIT TESTING
Testing done at Aerosol Research and Engineering Laboratories, complying with FDA Protocols in a FDA Certified Compliant Laboratory Net Log Reduction of Staphylococcus Epidermidis Bioaerosol

Average Percent Bacteria Reduction 0 minute 30 minutes 60 minutes 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% >99.99% >99.9999% (4-log) (6-log) Before Treatment After Treatment

Erwinia herbicola – Gram-negative Bacteria

Reduction of Airborne Contaminants
99.999%

Reduction after 60 minutes treatment


NEW ACTIVEPURE® MEDICAL UNIT TESTING
Testing done at Aerosol Research and Engineering Laboratories, complying with FDA Protocols in a FDA Certified Compliant Laboratory Net Log Erwinia Reduction of Bacillus Globigii (bacterial spores)

Average Percent Bacteria Reduction 0 minute 30 minutes 60 minutes 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% >99.99% >99.999% (4-log) (5-log) Before Treatment After Treatment

Aspergillus Niger Fungal Mold

Reduction of Airborne Contaminants
99.99%

Reduction after 60 minutes treatment


NEW ACTIVEPURE® MEDICAL UNIT TESTING
Testing done at Aerosol Research and Engineering Laboratories, complying with FDA Protocols in a FDA Certified Compliant Laboratory Net Log Reduction of Aspergillus Niger (fungal spores)

Average Percent Spore Forming Mold Reduction 0 minute 30 minutes 60 minutes 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% >99.9% >99.99% (3-log) (4-log) Before Treatment After Treatment

Bacillus Globigii Bacterial Mold

Reduction of Airborne Contaminants
99.99%

Reduction after 60 minutes treatment


NEW ACTIVEPURE® MEDICAL UNIT TESTING
Testing done at Aerosol Research and Engineering Laboratories, complying with FDA Protocols in a FDA Certified Compliant Laboratory Net Log Erwinia Reduction of Bacillus globigii (bacterial spores)

Average Percent Spore Forming Mold Reduction 0 minute 30 minutes 60 minutes 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% >99.9% >99.99% (3-log) (4-log) Before Treatment After Treatment

Scientific Proof

Proven testing results from active living environments

Hotel Fungus Chart

Click image to enlarge

Hotel Bacteria Chart

Click image to enlarge

Professional Baseball Chart

Click image to enlarge
Contact Us